Windlas Biotech - Quaterly Results

12 Aug 2025 Evaluate
The company witnessed a 19.95% growth in the revenue at Rs. 2100.90 millions for the quarter ended June 2025 as compared to Rs. 1751.53 millions during the year-ago period.The company has announced a 31.06% increase in its profits to Rs . 176.65  millions for the  quarter ended June 2025 compared to Rs. 134.79 millions in the corresponding quarter in the previous year.Operating profit for the quarter ended June 2025 rose to 317.63 millions as compared to 250.13 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 2100.90 1751.53 19.95 2100.90 1751.53 19.95 7598.78 6309.56 20.43
Other Income 52.39 41.33 26.76 52.39 41.33 26.76 176.46 134.68 31.02
PBIDT 317.63 250.13 26.99 317.63 250.13 26.99 1117.61 915.70 22.05
Interest 10.57 4.92 114.84 10.57 4.92 114.84 43.82 11.03 297.28
PBDT 307.06 245.21 25.22 307.06 245.21 25.22 1073.79 904.67 18.69
Depreciation 74.48 62.10 19.94 74.48 62.10 19.94 279.85 134.44 108.16
PBT 232.58 183.11 27.02 232.58 183.11 27.02 793.94 770.23 3.08
TAX 55.93 48.32 15.75 55.93 48.32 15.75 187.45 188.79 -0.71
Deferred Tax 0.40 2.20 -81.82 0.40 2.20 -81.82 4.72 15.35 -69.25
PAT 176.65 134.79 31.06 176.65 134.79 31.06 606.49 581.44 4.31
Equity 104.80 104.50 0.29 104.80 104.50 0.29 104.80 103.99 0.78
PBIDTM(%) 15.12 14.28 5.87 15.12 14.28 5.87 14.71 14.51 1.34

Windlas Biotech Share Price

770.65 -20.30 (-2.57%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×